| |
| |
|
| Insider
Information: |
Donegan Michael C |
| Relationship: |
Prin. Fin. and Acctg. ... |
| City: |
Boca Raton |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
61,853 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$95,872 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,853 |
|
|
| Total
Value |
$95,872 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -223.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Therapeuticsmd Inc |
TXMD |
Prin. Fin. and Acctg. ... |
2023-04-12 |
61,853 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TXMD |
Therapeuticsmd Inc |
Interim CFO/CAO/VP of Finance |
• – – |
2022-12-06 |
4 |
S |
$4.78 |
$4,345 |
D/D |
(910) |
4,554 |
0 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Interim CFO/CAO/VP of Finance |
• – – |
2022-12-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,476 |
5,464 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-24 |
4 |
S |
$5.31 |
$37 |
D/D |
(7) |
7,610 |
0 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-23 |
4 |
S |
$5.34 |
$6,950 |
D/D |
(1,302) |
7,617 |
0 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,365 |
8,919 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-27 |
4 |
S |
$5.09 |
$249 |
D/D |
(49) |
11,853 |
0 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-26 |
4 |
S |
$5.08 |
$8,371 |
D/D |
(1,648) |
11,902 |
0 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,940 |
13,550 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
CAO and VP Finance |
• – – |
2021-05-11 |
4 |
S |
$1.04 |
$5,036 |
D/D |
(4,842) |
14,158 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
CAO and VP Finance |
• – – |
2021-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,000 |
19,000 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Prin. Fin. and Acctg. Officer |
• – – |
2023-04-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
61,853 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
CAO and VP of Finance |
• – – |
2021-11-30 |
4 |
S |
$0.54 |
$15,947 |
D/D |
(29,790) |
99,368 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
CAO and VP of Finance |
• – – |
2021-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
115,000 |
129,158 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
